153 related articles for article (PubMed ID: 28450174)
1. Atorvastatin as a promising anticryptococcal agent.
Ribeiro NQ; Costa MC; Magalhães TFF; Carneiro HCS; Oliveira LV; Fontes ACL; Santos JRA; Ferreira GF; Araujo GRS; Alves V; Frases S; Paixão TA; de Resende Stoianoff MA; Santos DA
Int J Antimicrob Agents; 2017 Jun; 49(6):695-702. PubMed ID: 28450174
[TBL] [Abstract][Full Text] [Related]
2. A subdose of fluconazole alters the virulence of Cryptococcus gattii during murine cryptococcosis and modulates type I interferon expression.
Fontes AC; Bretas Oliveira D; Santos JR; Carneiro HC; Ribeiro NQ; Oliveira LV; Barcellos VA; Paixão TA; Abrahão JS; Resende-Stoianoff MA; Vainstein MH; Santos DA
Med Mycol; 2017 Feb; 55(2):203-212. PubMed ID: 27486215
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine Cryptococcosis.
Santos JR; Holanda RA; Frases S; Bravim M; Araujo Gde S; Santos PC; Costa MC; Ribeiro MJ; Ferreira GF; Baltazar LM; Miranda AS; Oliveira DB; Santos CM; Fontes AC; Gouveia LF; Resende-Stoianoff MA; Abrahão JS; Teixeira AL; Paixão TA; Souza DG; Santos DA
PLoS One; 2014; 9(11):e112669. PubMed ID: 25392951
[TBL] [Abstract][Full Text] [Related]
4. High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis.
Santos JRA; Ribeiro NQ; Bastos RW; Holanda RA; Silva LC; Queiroz ER; Santos DA
Sci Rep; 2017 Jul; 7(1):4661. PubMed ID: 28680034
[TBL] [Abstract][Full Text] [Related]
5. Treatment with pCramoll Alone and in Combination with Fluconazole Provides Therapeutic Benefits in
Jandú JJ; Costa MC; Santos JRA; Andrade FM; Magalhães TF; Silva MV; Castro MCAB; Coelho LCBB; Gomes AG; Paixão TA; Santos DA; Correia MTS
Front Cell Infect Microbiol; 2017; 7():211. PubMed ID: 28596945
[No Abstract] [Full Text] [Related]
6. Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis.
Ribeiro NQ; Santos APN; Emídio ECP; Costa MC; Freitas GJC; Carmo PHF; Silva MF; de Brito CB; de Souza DG; Paixão TA; Santos DA
Int J Antimicrob Agents; 2019 Sep; 54(3):301-308. PubMed ID: 31279153
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen.
Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K
J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis.
Santos JR; César IC; Costa MC; Ribeiro NQ; Holanda RA; Ramos LH; Freitas GJ; Paixão TA; Pianetti GA; Santos DA
Eur J Pharm Sci; 2016 Sep; 92():235-43. PubMed ID: 27235581
[TBL] [Abstract][Full Text] [Related]
9. Curcumin enhances the activity of fluconazole against Cryptococcus gattii-induced cryptococcosis infection in mice.
da Silva DL; Magalhães TF; Dos Santos JR; de Paula TP; Modolo LV; de Fátima A; Buzanello Martins CV; Santos DA; de Resende-Stoianoff MA
J Appl Microbiol; 2016 Jan; 120(1):41-8. PubMed ID: 26442997
[TBL] [Abstract][Full Text] [Related]
10. Heteroresistance to Itraconazole Alters the Morphology and Increases the Virulence of Cryptococcus gattii.
Ferreira GF; Santos JR; Costa MC; Holanda RA; Denadai ÂM; Freitas GJ; Santos ÁR; Tavares PB; Paixão TA; Santos DA
Antimicrob Agents Chemother; 2015 Aug; 59(8):4600-9. PubMed ID: 26014951
[TBL] [Abstract][Full Text] [Related]
11. Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii.
Mendes FE; Oliveira LV; Faria ES; Alvarenga DG; Pinto MR; Taborda CP; Soares BM; Cisalpino PS; Santos DA
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1525-32. PubMed ID: 20803047
[TBL] [Abstract][Full Text] [Related]
12. In vivo development of fluconazole resistance in serial Cryptococcus gattii isolates from a cat.
Sykes JE; Hodge G; Singapuri A; Yang ML; Gelli A; Thompson GR
Med Mycol; 2017 Jun; 55(4):396-401. PubMed ID: 28339594
[TBL] [Abstract][Full Text] [Related]
13. Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis.
Freitas GJC; Ribeiro NQ; Gouveia-Eufrasio L; Emidio ECP; Guimarães GM; César IC; Paixão TA; Oliveira JBS; Caza M; Kronstad JW; Santos DA
Int J Antimicrob Agents; 2023 Jul; 62(1):106807. PubMed ID: 37030471
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis.
Magalhães TFF; Costa MC; Holanda RA; Ferreira GF; Carvalho VSD; Freitas GJC; Ribeiro NQ; Emídio ECP; Carmo PHF; de Brito CB; de Souza DG; Rocha CEV; Paixão TA; de Resende-Stoianoff MA; Santos DA
Med Mycol; 2020 Aug; 58(6):835-844. PubMed ID: 31919505
[TBL] [Abstract][Full Text] [Related]
15. Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.
Silva VKA; May RC; Rodrigues ML
Med Mycol; 2020 Oct; 58(7):928-937. PubMed ID: 31915833
[TBL] [Abstract][Full Text] [Related]
16. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
Vu K; Gelli A
Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
[TBL] [Abstract][Full Text] [Related]
17. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
18. Fluconazole Susceptibility in Cryptococcus gattii Is Dependent on the ABC Transporter Pdr11.
Yang ML; Uhrig J; Vu K; Singapuri A; Dennis M; Gelli A; Thompson GR
Antimicrob Agents Chemother; 2015 Dec; 60(3):1202-7. PubMed ID: 26643330
[TBL] [Abstract][Full Text] [Related]
19. A murine model of Cryptococcus gattii meningoencephalitis.
Thompson GR; Wiederhold NP; Najvar LK; Bocanegra R; Kirkpatrick WR; Graybill JR; Patterson TF
J Antimicrob Chemother; 2012 Jun; 67(6):1432-8. PubMed ID: 22378683
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
